Loading...
XNYS
BIO
Market cap9.90bUSD
Oct 07, Last price  
367.92USD
1D
-0.25%
1Q
23.76%
Jan 2017
101.84%
Name

Bio Rad Laboratories Inc

Chart & performance

D1W1MN
XNYS:BIO chart
P/E
13.03
P/S
3.83
EPS
28.23
Div yield, %
—
Shrs. gr., 5y
-1.99%
Rev. gr., 5y
0.29%
Revenues
2.58b
+0.65%
1,273,930,0001,461,052,0001,764,365,0001,784,244,0001,927,118,0002,073,529,0002,069,235,0002,132,694,0002,175,044,0002,019,441,0002,068,172,0002,160,153,0002,290,109,0002,311,659,0002,545,626,0002,922,545,0002,802,249,0002,671,262,0002,566,500,0002,583,200,000
Net income
760m
P
103,263,00092,994,00089,510,000144,620,000185,490,000178,223,000169,234,00077,790,00088,845,000113,093,00028,125,000114,740,000360,996,0001,758,675,0003,814,229,0004,254,257,000-3,627,535,000-637,324,000-1,844,200,000759,900,000
CFO
532m
+16.92%
118,229,000191,580,000191,371,000325,074,000225,909,000262,735,000266,480,000169,136,000273,312,000186,210,000216,066,000104,137,000285,494,000457,897,000584,972,000669,464,000194,447,000374,943,000455,200,000532,200,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Bio-Rad Laboratories, Inc. creates, manufactures, and markets products essential for life science research and clinical diagnostics. Its operations span globally, covering territories such as the United States, Europe, Asia, Canada, and Latin America. The company's business is organized into two main divisions: Life Science and Clinical Diagnostics. The Life Science division develops and provides a comprehensive array of reagents, laboratory apparatus, and instruments. These are vital for various applications, including scientific research methodologies, biopharmaceutical production processes, and food quality testing. This segment dedicates its efforts to key areas within the life sciences, such as proteomics, genomics, biopharmaceutical development, cellular biology, and ensuring food safety. Its diverse clientele includes academic institutions (universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology researchers, and both food producers and testing laboratories. Conversely, the Clinical Diagnostics division specializes in designing, producing, selling, and supporting diagnostic test systems, informatics solutions, test kits, and specific quality control measures for clinical laboratories. This segment furnishes reagents, instrumentation, and software precisely tailored to address particular requirements within the in vitro diagnostics market. Its products are utilized by reference laboratories, hospital labs, state-operated newborn screening facilities, physicians' private offices, and blood transfusion centers. Furthermore, Bio-Rad offers systems and products designed for separating intricate chemical and biological substances, as well as for identifying, analyzing, and purifying their individual components. The company distributes its offerings through a multi-channel approach, leveraging both its direct sales force and a network of distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was established in 1952 and its corporate headquarters are located in Hercules, California.

Related entities

Subsidiaries (2)
BIO RAD LABORATORIES MANUFACTURE AND TRADE OF MEDICAL EQUIPMENT SINGLE MEMBER LIMITED LIABILITY COPANY
Bio - Rad Laboratories Gesellschaft mit beschränkter Haftung

Key people

Norman Schwartz
Chairman of the Board, Chief Executive Officer · since 2024
President, Chief Operating Officer · since 2024
Roop Lakkaraju
Chief Financial Officer, Executive Vice President · since 2024
James Barry
Executive Vice President, President - Life Science Group · since 2024
Michael Crowley
Executive Vice President - Global Commercial Operations · since 2014
Eva Anette Engelhardt
Executive Vice President, President of Clinical Diagnostics Group · since 2024
Courtney Enloe
Executive Vice President, General Counsel, Secretary · since 2024
Sedat Evran
Executive Vice President - Global Supply Chain · since 2023
Rajat Mehta
Executive Vice President - Global Commercial Operations · since 2025
Colleen Corey
Executive Vice President, Global Human Resources · since 2019
Allison Schwartz
Director · since 2022
Independent Director · since 2017
Lead Independent Director · since 2017
Independent Director · since 2017
Arnold Pinkston
Independent Director · since 2017
IPO date
Mar 17, 1980
Employees
8,200
Domiciled in
US
Incorporated in
US
Legal address
CORPORATION TRUST CENTER 1209 ORANGE ST
WILMINGTON, DE 19801
US
Headquarters
1000 Alfred Nobel Drive,
Hercules, CA 94547
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT